In her debut blog, Megan Bailey summarises an umbrella review of systematic reviews and meta-analyses on whether psychological trauma can be considered as a transdiagnostic risk factor for mental health disorders.
[read the full story...]Blood-based inflammatory markers in acute vs chronic schizophrenia
Éimear Foley summarises a recent meta-analysis, which looks at alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia.
[read the full story...]People with severe mental health difficulties are more likely to have poor dental health and dental disorders
Masuma Pervin Mishu summarises an umbrella review on the prevalence of dental disorders among people with severe mental illness.
[read the full story...]Optimal antipsychotic dosing in first-episode schizophrenia: how much is too little, too much, or just right?
Joe Pierre reports on the first published study exploring the relationship between antipsychotic dose and risk of relapse in first episode schizophrenia, which suggests that standard antipsychotic dosing is best for relapse prevention.
[read the full story...]Uncertainties about stopping or reducing antipsychotics as shared by families
Amelia Talbot considers a qualitative study that explores family members’ perspectives on reducing or discontinuing antipsychotic medication.
[read the full story...]Can therapeutic alliance help prevent suicide in people with psychosis?
Melanie Lafanechere and Dafni Katsampa summarise a study on the therapeutic alliance and suicidal experiences in people with psychosis receiving Cognitive Behavioural Suicide Prevention Therapy.
[read the full story...]An INTREPID journey into the epidemiological landscape of psychosis in the Global South
Shuichi Suetani and Jon Paul Teo discuss the International Research Program on Psychotic Disorders in Diverse Settings (INTREPID II) study, which investigates the epidemiology of untreated psychoses in 3 diverse settings in the Global South.
[read the full story...]Can social recovery therapy improve social disability in young people?
In her debut blog, Jude Madani summarises the findings of the PRODIGY trial, which looked at the clinical and cost-effectiveness of social recovery therapy for the prevention and treatment of long-term social disability among young people with emerging severe mental illness.
[read the full story...]Do different groups of people with schizophrenia respond differently to different antipsychotics?
Murtada Alsaif considers a systematic review and meta-analysis published in the Lancet Psychiatry exploring the response of different subgroups of patients with schizophrenia to different antipsychotic drugs.
[read the full story...]Oral health interventions for people with severe mental illness: what enables and prevents people from accessing them?
Vishal Aggarwal considers the findings of a recent qualitative study, which looks at the contextual factors, barriers, and facilitators to accessing oral health interventions for people with severe mental illness.
[read the full story...]